In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......
Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria, reports Sohini Das. IMAGE: A woman receives a dose of Covishield at a vaccination centre......
The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now,......
The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron. IMAGE: A nurse prepares......
The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to......
The six-decade-old pharmaceutical company VHB Life Sciences will come out with an initial public offer in July this year to fund its Rs 400-crore (Rs 4 billion) expansion plans in the near future,......
UK health regulatory authority enforces strict norms for export, in wake of EU directive. Indian ayurvedic medicines manufacturers are set to face a tough time as far as exports to European......
According to the chairman, there will be an annual loss of Rs 100 crore due to the MHRA alert on Waluj plant Following the import alert issued by the US FDA, another global medical regulator, UK......
Ranbaxy Ltd has been asked by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the largest drug regulator in Europe, to recall its drugs used to treat skin infections.Ranbaxy (UK)......
Close on the heels of the Canadian government warning against the use of Indian herbal remedies, Britain's healthcare agency has said herbal remedies available in the country may contain dangerous......